MeiraGTx to present 3-year data from gene therapy xerostomia study

April 14, 2026 8:31 AM

MeiraGTx Holdings plc (NASDAQ: MGTX) announced it will present three-year follow-up data from its Phase 1 AQUAx clinical study of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found